½ÃÀ庸°í¼­
»óǰÄÚµå
1602819

¼¼°èÀÇ Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå : Á¦Ç°º°, Çüź°, ¿ëµµº° - ¿¹Ãø(2025-2030³â)

Anticoagulant Rodenticides Market by Product (1st Generation Anticoagulant, Second-Generation Anticoagulants), Form (Pellets, Powders, Sprays), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀº 2023³â¿¡ 9¾ï 1,985¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 10¾ï 3,996¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 13.54%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 22¾ï 3,794¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç×ÀÀ°í¼º »ì¼­Á¦´Â ºñŸ¹Î KÀÇ ´ë»ç¸¦ ÀúÇØÇÔÀ¸·Î½á ³»ÃâÇ÷À» ÀÏÀ¸Å°°í, ÁãÀÇ °³Ã¼¼ö¸¦ Á¦¾îÇϱâ À§ÇØ »ç¿ëµÇ´Â ¹°ÁúÀÔ´Ï´Ù. »ì¼­Á¦´Â ÁãÀÇ Ä§ÀÔ¿¡ µû¸¥ Àç»ê ÇÇÇØ¿Í °Ç°­ ÇÇÇØ¸¦ ¸·±â À§ÇØ µµ½Ã, ³ó¾÷, °ø¾÷ ÇöÀå¿¡¼­ »©³õÀ» ¼ö ¾ø´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ »ì¼­Á¦ÀÇ ¿ëµµ´Â ³ó¾÷, °øÁߺ¸°Ç, ÁְŰø°£ µî ´Ù¾çÇÑ ºÐ¾ß¿¡ ÀÖÀ¸¸ç ÃÖÁ¾ »ç¿ëÀÚ´Â ³ó¾÷ »ý»êÀÚ, ÇØÃæ±¸Á¦ ¼­ºñ½º, ÁÖÅà ¼ÒÀ¯ÀÚÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖµÈ ¿øµ¿·ÂÀº, µµ½ÃÈ­ÀÇ ÁøÀü¿¡ ÀÇÇÑ È¿°úÀûÀÎ ÇØÃæ ±¸Á¦ ¼Ö·ç¼ÇÀÇ ¿ä±¸ÀÇ °íÁ¶¿Í ¼³Ä¡·ù¿¡ ÀÇÇÑ °øÁß À§»ý ¸®½ºÅ©¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶ÀÔ´Ï´Ù. Á¾ÇÕÀûÀÎ À¯ÇØ»ý¹° °ü¸® ¼Ö·ç¼ÇÀ» Àǹ«È­ÇÏ´Â ±ÔÁ¦ ƲÀÌ °­È­µÈ °ÍÀÌ ¼ö¿ä¸¦ ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ºñÁî´Ï½º Âù½º´Â, ȯ°æ ģȭÀûÀÌ°í ¸®½ºÅ©°¡ ÀûÀº »ì¼­Á¦ÀÇ °³¹ßÀ̳ª, ºñÇ¥ÀûÁ¾¿¡ ´ëÇÑ ¿ì¹ßÀûÀÎ Æø·Î¸¦ ÃÖ¼ÒÇÑÀ¸·Î ¾ïÁ¦ÇÏ´Â °íµµÀÇ º£ÀÌÆ® ±â¼ú¿¡ ÀÇÇÑ Á¦Ç°ÀÇ È¿´É °­È­¿¡ ÀÖ½À´Ï´Ù. ±×·¯³ª, °úÁ¦·Î¼­´Â, Áö¼Ó °¡´ÉÇÑ ÇØ°áÃ¥À» ¿ä±¸ÇÏ´Â ¼ÒºñÀÚ ¼ö¿äÀÇ °íÁ¶¿Í ÇÔ²², ¾ß»ýµ¿¹°À̳ª ¾Ö¿Ïµ¿¹°ÀÇ 2Â÷ Áßµ¶À¸·Î À̾îÁú °¡´É¼ºÀÌ ÀÖ´Â ÀÌ·¯ÇÑ È­Çй°ÁúÀÇ È¯°æ¿¡ ´ëÇÑ ¿µÇâÀ¸·Î ÀÇÇÑ ¾ö°ÝÇÑ ±ÔÁ¦¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±âÁ¸ÀÇ Ç×ÀÀ°íÁ¦¿¡ ´ëÇÑ ¼³Ä¡·ùÀÇ ³»¼º ¹ß´ÞÀÌ Å« Àå¾Ö°¡ µÇ°í ÀÖ½À´Ï´Ù. ÇâÈÄ ±â¼ú Çõ½ÅÀº È¿°ú¸¦ ÃÖÀûÈ­Çϸ鼭 ºñÇ¥Àû ³ëÃâ°ú ³»¼ºÀ» ÃÖ¼ÒÈ­ÇÏ´Â À¯ÀüÀÚ ±â¹Ý ¼Ö·ç¼Ç°ú Á¤¹Ð Àü´Þ ½Ã½ºÅÛ¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. °Ô´Ù°¡ ½Ç½Ã°£ ¼³Ä¡·ù ¸ð´ÏÅ͸µ°ú ÄÁÆ®·Ñ¿¡ µðÁöÅÐ µµ±¸¸¦ Ȱ¿ëÇϸé È¿À²°ú »ç¿ëÀÚ µµÀÔÀÌ ÃËÁøµÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº Àû´çÈ÷ ÅëÇյǾî ÀÖÀ¸¸ç ÁÖ¿ä ±â¾÷µéÀº ¿¬±¸°³¹ßÀ̳ª Àü·«Àû Á¦ÈÞ¿¡ ÅõÀÚÇÏ¿© Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ´Ù¾çÈ­Çϰí Áö¿ªÀû À§»óÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¼ºÀåÀ» ½ÇÇöÇϱâ À§Çؼ­´Â ±â¾÷Àº ±ÔÁ¦ µ¿Çâ¿¡ ´ëÇÑ ´ëÀÀÀ» ¿ì¼±½ÃÇϰí, ±â¼ú ±â¾÷°úÀÇ ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÏ¿© µðÁöÅÐ ÇØÃæ ±¸Á¦ ¼Ö·ç¼ÇÀ» ÁøÈ­½Ã۰í, Áö¼Ó °¡´É¼ºÀ» °­È­ÇÏ¿© ¼ÒºñÀÚ ¼ö¿ä¸¦ ÃæÁ·½ÃÄÑ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀο¡ ´ëóÇÔÀ¸·Î½á ±â¾÷Àº ½ÃÀåÀÇ º¹À⼺À» ±Øº¹ÇÏ°í »õ·Î¿î ¼ºÀå ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, °ß°íÇϰí Áö¼Ó °¡´ÉÇÑ »ç¾÷ ¼ºÀåÀ» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 9¾ï 1,985¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 10¾ï 3,996¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 22¾ï 3,794¸¸ ´Þ·¯
CAGR(%) 13.54%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç °áÁ¤, »õ·Î¿î ºñÁî´Ï½º Âù½ºÀÇ È¹µæÀ» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Æ÷°ýÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼³Ä¡·ù °ü·Ã ÁúȯÀÌ ³ôÀº À¯Çà
    • ³ó¾÷ ºÎ¹®À¸·ÎºÎÅÍÀÇ Å« ¼ö¿ä
    • ¿ÍÆÄ¸° ³»¼º ÁãÀÇ ÃâÇö
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÎü¿¡ ´ëÇÑ ¾Ç¿µÇâ°ú »ì¼­Á¦¿¡ ´ëÇÑ ³»¼º Áõ°¡ÀÇ ¹®Á¦
  • ½ÃÀå ±âȸ
    • ȯ°æ ģȭÀûÀÎ Ç×ÀÀ°í¼º »ì¼­Á¦ °³¹ß
    • Áã ±¸Á¦¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø
  • ½ÃÀåÀÇ °úÁ¦
    • »ì¼­Á¦ Á¦Ç°ÀÇ ÀϺο¡ ´ëÇÑ Á¤ºÎÀÇ ±ÔÁ¦

Porter's Five Forces : Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼³Ä¡·ù °ü·Ã ÁúȯÀÇ ³ôÀº ¸¸¿¬·ü
      • ³ó¾÷ ºÐ¾ß·ÎºÎÅÍÀÇ Å« ¼ö¿ä
      • ¿ÍÆÄ¸° ³»¼º ÁãÀÇ ÃâÇö
    • ¾ïÁ¦¿äÀÎ
      • Àΰ£ÀÇ °Ç°­¿¡ ÇØ·Î¿î ¿µÇâ°ú »ì¼­Á¦¿¡ ´ëÇÑ ³»¼º Áõ°¡ÀÇ ¹®Á¦
    • ±âȸ
      • ģȯ°æ Ç×ÀÀ°í¼º »ì¼­Á¦ °³¹ß
      • Áã ±¸Á¦¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø
    • °úÁ¦
      • ÀϺΠ»ì¼­Á¦¿¡ ´ëÇÑ Á¤ºÎÀÇ ±ÔÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå : Á¦Ç°º°

  • Á¦1¼¼´ë Ç×ÀÀ°íÁ¦
    • Ŭ·Î·ÎÆÄ½Ã³í
    • Äí¸¶Åׯ®¶ó¸±
    • ÁöÆÄ½Ã³í
    • ¿ÍÆÄ¸°
  • Á¦2¼¼´ë Ç×ÀÀ°íÁ¦
    • ºê·ÎµðÆÄÄÞ
    • ºê·Î¸¶µð¿Ã·Ð
    • ÁöÆä³ªÄñ
    • µðÆäƼ¾Æ·Ð
    • ÈÄ·ÎÄí¸¶Ææ

Á¦7Àå Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå : Çüź°

  • Æç·¿
  • ºÐ¸»
  • ½ºÇÁ·¹ÀÌ

Á¦8Àå Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå : ¿ëµµº°

  • ³ó¾÷ ºÐ¾ß
  • ÁÖÅÿë
  • µµ½Ã Á߽ɺÎ
  • â°í

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç×ÀÀ°í¼º »ì¼­Á¦ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abell Group of Companies
  • Anticimex
  • BASF SE
  • Bayer AG
  • Bell Laboratories Inc.
  • BioGuard Pest Control LLC
  • EcoClear Products and Natural Product Holdings, LLC
  • Ecolab Inc.
  • Futura Germany
  • Impex Europa SL
  • JT Eaton & Co., Inc.
  • Liphatech, Inc.
  • Neogen Corporation
  • Pelgar International
  • Rentokil Initial Plc
  • Syngenta AG
  • The Terminix International Company Limited
  • Truly Nolen, Inc.
  • UPL Limited
AJY 24.12.13

The Anticoagulant Rodenticides Market was valued at USD 919.85 million in 2023, expected to reach USD 1,039.96 million in 2024, and is projected to grow at a CAGR of 13.54%, to USD 2,237.94 million by 2030.

Anticoagulant rodenticides are substances used to control rodent populations by causing internal bleeding through the inhibition of Vitamin K metabolism. They are essential in urban, agricultural, and industrial settings to prevent property damage and health risks associated with rodent infestations. The application of these rodenticides spans various sectors, including agriculture, public health, and residential spaces, with end users comprising agricultural producers, pest control services, and homeowners. Market growth is primarily driven by increasing urbanization, which heightens the need for effective pest control solutions, and rising awareness about public health risks due to rodents. Enhanced regulatory frameworks mandating integrated pest management solutions further fuel demand. Potential opportunities lie in developing eco-friendly, reduced-risk rodenticides and enhancing product efficacy with advanced bait technologies to minimize accidental exposures to non-target species. However, challenges include stringent regulations due to the environmental impact of these chemicals, which can lead to secondary poisoning of wildlife and pets, alongside rising consumer demand for sustainable solutions. Moreover, the development of rodent resistance to traditional anticoagulants poses a significant hurdle. Future innovation could focus on genetic-based solutions or precision delivery systems that minimize non-target exposure and resistance while optimizing effectiveness. Additionally, leveraging digital tools for real-time rodent monitoring and control could enhance efficiency and user adoption. The market is moderately consolidated, with key players investing in R&D and strategic collaborations to diversify product portfolios and expand regional presence. To capture growth, businesses should prioritize compliance with regulatory trends, nurture partnerships with technology firms to advance digital pest control solutions, and strengthen sustainability credentials to meet consumer demand. By addressing these factors, companies can navigate the complexities of the market and capitalize on emerging opportunities, ensuring robust and sustainable business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 919.85 million
Estimated Year [2024] USD 1,039.96 million
Forecast Year [2030] USD 2,237.94 million
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anticoagulant Rodenticides Market

The Anticoagulant Rodenticides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of rodent-related diseases
    • Significant demand from the agriculture sector
    • Emergence of warfarin-resistant strains of rats
  • Market Restraints
    • Harmful effects on human health and issues of increasing resistance to rodenticides
  • Market Opportunities
    • Development of an eco-friendly anticoagulant rodenticide
    • Government support for rodent control
  • Market Challenges
    • Government restrictions on some rodenticide products

Porter's Five Forces: A Strategic Tool for Navigating the Anticoagulant Rodenticides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anticoagulant Rodenticides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anticoagulant Rodenticides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anticoagulant Rodenticides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anticoagulant Rodenticides Market

A detailed market share analysis in the Anticoagulant Rodenticides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anticoagulant Rodenticides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anticoagulant Rodenticides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anticoagulant Rodenticides Market

A strategic analysis of the Anticoagulant Rodenticides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anticoagulant Rodenticides Market, highlighting leading vendors and their innovative profiles. These include Abell Group of Companies, Anticimex, BASF SE, Bayer AG, Bell Laboratories Inc., BioGuard Pest Control LLC, EcoClear Products and Natural Product Holdings, LLC, Ecolab Inc., Futura Germany, Impex Europa S.L., JT Eaton & Co., Inc., Liphatech, Inc., Neogen Corporation, Pelgar International, Rentokil Initial Plc, Syngenta AG, The Terminix International Company Limited, Truly Nolen, Inc., and UPL Limited.

Market Segmentation & Coverage

This research report categorizes the Anticoagulant Rodenticides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 1st Generation Anticoagulant and Second-Generation Anticoagulants. The 1st Generation Anticoagulant is further studied across Chlorophacinone, Coumatetralyl, Diphacinone, and Warfarin. The Second-Generation Anticoagulants is further studied across Brodifacoum, Bromadiolone, Difenacoum, Difethialone, and Flocoumafen.
  • Based on Form, market is studied across Pellets, Powders, and Sprays.
  • Based on Application, market is studied across Agricultural Fields, Residential, Urban Centers, and Warehouses.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of rodent-related diseases
      • 5.1.1.2. Significant demand from the agriculture sector
      • 5.1.1.3. Emergence of warfarin-resistant strains of rats
    • 5.1.2. Restraints
      • 5.1.2.1. Harmful effects on human health and issues of increasing resistance to rodenticides
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of an eco-friendly anticoagulant rodenticide
      • 5.1.3.2. Government support for rodent control
    • 5.1.4. Challenges
      • 5.1.4.1. Government restrictions on some rodenticide products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anticoagulant Rodenticides Market, by Product

  • 6.1. Introduction
  • 6.2. 1st Generation Anticoagulant
    • 6.2.1. Chlorophacinone
    • 6.2.2. Coumatetralyl
    • 6.2.3. Diphacinone
    • 6.2.4. Warfarin
  • 6.3. Second-Generation Anticoagulants
    • 6.3.1. Brodifacoum
    • 6.3.2. Bromadiolone
    • 6.3.3. Difenacoum
    • 6.3.4. Difethialone
    • 6.3.5. Flocoumafen

7. Anticoagulant Rodenticides Market, by Form

  • 7.1. Introduction
  • 7.2. Pellets
  • 7.3. Powders
  • 7.4. Sprays

8. Anticoagulant Rodenticides Market, by Application

  • 8.1. Introduction
  • 8.2. Agricultural Fields
  • 8.3. Residential
  • 8.4. Urban Centers
  • 8.5. Warehouses

9. Americas Anticoagulant Rodenticides Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anticoagulant Rodenticides Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anticoagulant Rodenticides Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abell Group of Companies
  • 2. Anticimex
  • 3. BASF SE
  • 4. Bayer AG
  • 5. Bell Laboratories Inc.
  • 6. BioGuard Pest Control LLC
  • 7. EcoClear Products and Natural Product Holdings, LLC
  • 8. Ecolab Inc.
  • 9. Futura Germany
  • 10. Impex Europa S.L.
  • 11. JT Eaton & Co., Inc.
  • 12. Liphatech, Inc.
  • 13. Neogen Corporation
  • 14. Pelgar International
  • 15. Rentokil Initial Plc
  • 16. Syngenta AG
  • 17. The Terminix International Company Limited
  • 18. Truly Nolen, Inc.
  • 19. UPL Limited
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦